Linked Life Data

11252687

Source:http://linkedlifedata.com/resource/pubmed/id/11252687

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-3-16
pubmed:abstractText
To compare the incidence of selected spontaneously reported adverse events (AEs) in patients with osteoarthritis (OA) treated with rofecoxib (VIOXX, 12.5 mg qd) or Arthrotec (diclofenac 50 mg/misoprostol 200 mcg bid).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0300-9742
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-24
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11252687-Abdominal Pain, pubmed-meshheading:11252687-Adult, pubmed-meshheading:11252687-Aged, pubmed-meshheading:11252687-Aged, 80 and over, pubmed-meshheading:11252687-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:11252687-Cyclooxygenase Inhibitors, pubmed-meshheading:11252687-Diarrhea, pubmed-meshheading:11252687-Diclofenac, pubmed-meshheading:11252687-Double-Blind Method, pubmed-meshheading:11252687-Drug Combinations, pubmed-meshheading:11252687-Female, pubmed-meshheading:11252687-Humans, pubmed-meshheading:11252687-Lactones, pubmed-meshheading:11252687-Male, pubmed-meshheading:11252687-Middle Aged, pubmed-meshheading:11252687-Misoprostol, pubmed-meshheading:11252687-Osteoarthritis, pubmed-meshheading:11252687-Severity of Illness Index, pubmed-meshheading:11252687-Sulfones, pubmed-meshheading:11252687-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.
pubmed:affiliation
Clínica San Felipe, Lima, Peru.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't